HUB Investment Partners’s iShares Biotechnology ETF IBB Stock Holding History

HUB Investment Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$386K	Buy	2,030 +300	+17%	+$51.6K	0.01%	858
2026 Q1	$292K	Sell	1,730 -45	-3%	-$7.7K	0.01%	826
2025 Q4	$300K	Hold	1,775	–	–	0.01%	670
2025 Q3	$256K	Buy	1,775 +125	+8%	+$17.1K	0.01%	608
2025 Q2	$209K	Hold	1,650	–	–	0.01%	619
2025 Q1	$211K	Sell	1,650 -1,227	-43%	-$166K	0.01%	540
2024 Q4	$380K	Buy	2,877 +1,165	+68%	+$164K	0.02%	355
2024 Q3	$249K	Buy	1,712 +150	+10%	+$21.7K	0.01%	430
2024 Q2	$214K	Sell	1,562 -603	-28%	-$80.5K	0.01%	429
2024 Q1	$297K	Buy	2,165 +191	+10%	+$26.1K	0.02%	362
2023 Q4	$268K	Buy	+1,974	New	+$241K	0.02%	334
2021 Q2	–	Sell	-3,569	Closed	-$537K	–	229
2021 Q1	$537K	Sell	3,569 -1,196	-25%	-$190K	0.16%	116
2020 Q4	$645K	Buy	+4,765	New	+$681K	0.29%	80

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

HUB Investment Partners's IBB Position: Q2 2026 in Review

HUB Investment Partners increased its iShares Biotechnology ETF (IBB) stake by 17% in Q2 2026, buying an estimated $51.6K and bringing the position to 2,030 shares worth $386K. The position accounts for 0.01% of the portfolio, ranked #858.

HUB Investment Partners first reported a position in IBB in Q4 2020 and has held it in 13 quarters since. The position peaked at $645K in Q4 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

HUB Investment Partners held 2,030 shares of iShares Biotechnology ETF worth $386K as of Q2 2026.
HUB Investment Partners bought 300 iShares Biotechnology ETF shares in Q2 2026, an estimated $51.6K.
iShares Biotechnology ETF made up 0.01% of HUB Investment Partners's portfolio in Q2 2026, its #858 holding.
HUB Investment Partners first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 13 quarters since.
HUB Investment Partners's iShares Biotechnology ETF position peaked at $645K in Q4 2020.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.